Related Experiment Video
Updated: Oct 25, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Pulmonary vein narrowing after voltage-guided adjunctive pulmonary vein sleeve pulsed field ablation
Takehito Sasaki1, Taiki Masuyama1, Kentaro Minami2
1Division of Cardiology, Gunma Prefectural Cardiovascular Center, 3-12 Kameizumi-machi, Maebashi City, Gunma, 371-0004, Japan.
Background:
Pulsed field ablation (PFA) for pulmonary vein (PV) isolation (PVI) has been associated with a low risk of PV stenosis when performed using the standard ostial workflow. However, the risk of PV narrowing after adjunctive PV sleeve PFA remains insufficiently evaluated.
Objective:
To assess PV narrowing after voltage-guided adjunctive PV sleeve PFA.
Methods:
We retrospectively studied 147 patients who underwent an initial pentaspline PFA-based PVI for atrial fibrillation. In addition to standard ostial PVI, voltage-guided PFA applications were delivered to target PV sleeve potentials identified on pre-ablation voltage mapping. Contrast-enhanced computed tomography was performed before and approximately six months after ablation. PV cross-sectional areas (PVAs) were measured at predefined levels, and the maximum PVA reduction rate was defined as ΔPVA. Significant PV narrowing was defined as ΔPVA ≥25%.
Results:
Post-ablation PVA was significantly smaller than pre-ablation PVA at all PV sites. The median ΔPVA was 5.4%, 6.4%, 4.6%, and 4.0% in the left superior, left inferior, right superior, and right inferior PVs, respectively, and differed significantly among the four PV sites (P = 0.012). No significant PV narrowing was observed in this cohort.
Conclusions:
In patients undergoing an initial PFA-based PVI, no significant PV narrowing was observed approximately six months after voltage-guided adjunctive PV sleeve PFA using a pentaspline catheter. Further controlled studies with larger populations and longer follow-up are needed to better characterize the safety and clinical utility of this strategy.

